CHIMERIC ANTISENSE OLIGONUCLEOTIDES AND CELL TRANSFECTING FORMULATIONS THEREOF
    1.
    发明公开
    CHIMERIC ANTISENSE OLIGONUCLEOTIDES AND CELL TRANSFECTING FORMULATIONS THEREOF 有权
    嵌合反义寡核苷酸和ZELLTRANSFEKTIONS它们的组合物

    公开(公告)号:EP1144609A2

    公开(公告)日:2001-10-17

    申请号:EP00959373.2

    申请日:2000-08-25

    IPC分类号: C12N15/00

    摘要: Chimeric oligonucleotide of the formula 5'-W-X1-Y-X2-Z-3', where W represents a 5'-O-alkyl nucleotide, each of X?1 and X2¿ represented a block of seven to twelve phosphodiester-linked 2'-O-alkyl ribonucleotides, Y represents a block of five to twelve phosphorothioate-linked deoxyribonucleotides, and Z represents a blocking group effective to block nuclease activity at the 3' end of the oligonucleotide, are described. These compounds exhibit high resistance to endo- and exonucleases, high sequence specificity, and the ability to activate RNAse H, as evidenced by efficient and long-lasting suppression of target mRNA. The oligonucleotides are preferably transfected into cells in formulations containing a lipid-peptoid conjugate carrier molecule of the formula L-linker-[N(CH¿2?CH2NH2)CH2(C=O)-N(CH2CH2R)CH2(C=O)-N(CH2CH2R)CH2(C=O)]3-NH2, where L is a lipid moiety, including a steroid, and each group R is independently selected from alkyl, aminoalkyl, and aralkyl.

    TETRASPAN PROTEIN AND USES THEREOF
    4.
    发明公开
    TETRASPAN PROTEIN AND USES THEREOF 审中-公开
    TETRA SPAN蛋白及其用途

    公开(公告)号:EP1309682A2

    公开(公告)日:2003-05-14

    申请号:EP01952721.7

    申请日:2001-07-13

    摘要: Inhibitors of TSPAN-7 are provided that reduce the expression or biological activities of TSPAN-7 in a mammalian cell. TSPAN-7 inhibitors include antisense molecules, ribozymes, antibodies and antibody fragments, proteins and polypeptides as well as small molecules. TSPAN-7 inhibitors find use in compositions and methods for decreasing TSPAN-7 gene expression as well as methods for inhibiting proliferation of mammalian cells, including tumor cells, methods for decreasing the side effects of cancer therapy and methods for treating neoplastic diseases. Also provided are nucleic acids encoding a new member of the tetraspan family, TSPAN-7, and polypeptides encoded thereby.